Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sucha Nand

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Neurosurgery Clinics of North America|September 19, 2018
Genetics of Hypercoagulable and Hypocoagulable StatesDaulath Singh, Arjun Natarajan, Sucha Nand, et al.
European Journal of Haematology|January 13, 2006
A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapyMohtashim Naeem, Kathleen Harrison, Kevin Barton, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 11, 2021
Hypercoagulability of COVID-19 and Neurological Complications: A ReviewPatrick Moore, Fatema Esmail, Shuai Qin, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Thromboembolism in cancer patients: pathogenesis and treatmentMatthew Adess, Robert Eisner, Sucha Nand, et al.
Diagnostic Cytopathology|March 14, 2014
Anaplastic large cell lymphoma involving the urinary bladder: a case report and review of the literatureHaiyan Chen, Yanxia Li, Sucha Nand, et al.
Leukemia|October 14, 2018
Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studiesMegan Othus, Mikkael A Sekeres, Sucha Nand, et al.
Leukemia & Lymphoma|November 21, 2008
Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialSucha Nand, John Godwin, Scott Smith, et al.
Case Reports in Transplantation|August 9, 2020
Kidney Transplantation for Erdheim-Chester DiseaseJongwon Yoo, Cynthia Gunsteen, Sima Patel, et al.
American Journal of Hematology|June 2, 2005
Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibitionSerhan Alkan, Qin Huang, Melek Ergin, et al.
Blood|October 5, 2013
A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemiaSucha Nand, Megan Othus, John E Godwin, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Neurosurgery Clinics of North America|September 19, 2018
Genetics of Hypercoagulable and Hypocoagulable StatesDaulath Singh, Arjun Natarajan, Sucha Nand, et al.
European Journal of Haematology|January 13, 2006
A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapyMohtashim Naeem, Kathleen Harrison, Kevin Barton, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 11, 2021
Hypercoagulability of COVID-19 and Neurological Complications: A ReviewPatrick Moore, Fatema Esmail, Shuai Qin, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Thromboembolism in cancer patients: pathogenesis and treatmentMatthew Adess, Robert Eisner, Sucha Nand, et al.
Diagnostic Cytopathology|March 14, 2014
Anaplastic large cell lymphoma involving the urinary bladder: a case report and review of the literatureHaiyan Chen, Yanxia Li, Sucha Nand, et al.
Leukemia|October 14, 2018
Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studiesMegan Othus, Mikkael A Sekeres, Sucha Nand, et al.
Leukemia & Lymphoma|November 21, 2008
Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialSucha Nand, John Godwin, Scott Smith, et al.
Case Reports in Transplantation|August 9, 2020
Kidney Transplantation for Erdheim-Chester DiseaseJongwon Yoo, Cynthia Gunsteen, Sima Patel, et al.
American Journal of Hematology|June 2, 2005
Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibitionSerhan Alkan, Qin Huang, Melek Ergin, et al.
Blood|October 5, 2013
A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemiaSucha Nand, Megan Othus, John E Godwin, et al.
Pageof 3